Press Releases Orexo AB

Equities

ORX

SE0000736415

Real-time Estimate Cboe Europe Other stock markets 07:17:10 2024-05-23 am EDT			5-day change	1st Jan Change
21.4 ^SEK	-1.61%		+5.85%	+40.36%

May. 08	Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024
Apr. 17	Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm	May. 10	AQ
Orexo Q1 2024 Interim Report	May. 08	AQ
Fentanyl awareness day: The synthetic opioid fentanyl increasingly poisons young Americans	May. 07	PU
Orexo : Invitation to presentation of Orexo´s Q1 2024 Interim Report	May. 02	PU
Report from Orexo AB's annual general meeting, 26 April 2024	Apr. 26	AQ
Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US	Apr. 17	AQ
Orexo announces that the condition for early redemption of its existing bonds has been fulfilled	Apr. 02	AQ
Orexo publishes the Annual and Sustainability Report for 2023	Mar. 28	AQ
Correction: Notice of Annual General Meeting of Orexo	Mar. 15	AQ
Notice of Annual General Meeting of Orexo	Mar. 15	AQ
Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds	Mar. 13	AQ
Orexo contemplates issuance of senior secured callable floating rate social bonds and announces a conditional tender offer for its existing bonds	Mar. 08	AQ
Orexo strengthens its sustainability work by establishing a social financing framework	Mar. 08	AQ
Orexo and Sobi agree to advance feasibility study with AmorphOX	Feb. 12	AQ
Orexo Interim Report Q4 2023, incl. Full Year Report	Feb. 08	AQ
Orexo's OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC	Feb. 06	AQ
Orexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose	Nov. 28	AQ
Orexo Q3 2023 Interim Report	Nov. 02	AQ
Orexo announces changes in the company's Board of Directors	23-10-30	AQ
Orexo announces changes in the company's Board of Directors	23-10-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Orexo AB

Equities

ORX

SE0000736415

Press Releases

Filters